ArticleMikrochimica acta2023
Dual-ligand 3D lammelar chiral metal-organic framework for capillary electrochromatographic enantioseparations.
Article in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- [Recent progress in constructions and applications of chiral porous framework-based chromatographic stationary phases].Se pu = Chinese journal of chromatography · 2026Article
- Development and application of chiral separation technology based on chiral metal-organic frameworks.Journal of pharmaceutical analysis · 2025Review
- [Preparation of chiral metal organic framework modified silica monolithic capillary column and its application in enantioseparations of chiral drugs].Se pu = Chinese journal of chromatography · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Dual-ligand metal-organic frameworks (MOFs) based on tryptophan and camphoric acid were designed and synthesized as the stationary phase of the capillary electrochromatography (CEC) system. This CEC system showed significantly improved enantioseparation ability for nine drugs, compared with the single-ligand MOF stationary phase. Characterization methods such as N
Indexed as
Identifiers
37464133What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.